Oncocyte Corp Annual Selling and Marketing Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Oncocyte Corp quarterly/annual Selling and Marketing Expense history and growth rate from 2015 to 2023.
  • Oncocyte Corp Selling and Marketing Expense for the quarter ending June 30, 2024 was $853K, a 5.96% increase year-over-year.
  • Oncocyte Corp Selling and Marketing Expense for the twelve months ending June 30, 2024 was $2.99M, a 33.7% increase year-over-year.
  • Oncocyte Corp annual Selling and Marketing Expense for 2023 was $2.8M, a 147% increase from 2022.
  • Oncocyte Corp annual Selling and Marketing Expense for 2022 was $1.13M, a 105% increase from 2021.
  • Oncocyte Corp annual Selling and Marketing Expense for 2021 was $552K, a 91.5% decline from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.8M +$1.66M +147% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $1.13M +$580K +105% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $552K -$5.94M -91.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-12
2020 $6.49M +$4.33M +200% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $2.16M +$483K +28.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-19
2018 $1.68M -$762K -31.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $2.44M +$1.25M +104% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $1.2M +$874K +270% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $324K Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.